Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX)
| Previous close | 14.59 |
| Open | 14.78 |
| Bid | 15.55 x 50000 |
| Ask | 15.57 x 194200 |
| Day's range | 14.78 - 15.58 |
| 52-week range | 12.39 - 15.94 |
| Volume | |
| Avg. volume | 3,512,174 |
| Market cap | 14.988B |
| Beta (5Y monthly) | 0.48 |
| PE ratio (TTM) | 10.29 |
| EPS (TTM) | 1.51 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 0.78 (5.36%) |
| Ex-dividend date | 22 Mar 2024 |
| 1y target est | 18.53 |
PR NewswireGenomma Lab Internacional Announces Results for the First Quarter 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.
PR NewswireGenomma Lab Internacional S.A.B. de C.V. First Quarter 2024 Earnings Results Conference Call
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its First Quarter 2024 Earnings Results on Wednesday, April 24, 2024, after the Mexican Stock Exchange (BMV) close. The company also announced that it will hold a conference call on Thursday, April 25, 2024, at 1 p.m. ET to discuss its quarterly financial results.
PR NewswireGENOMMA LAB INTERNACIONAL ANNOUNCES SEVENTH DIVIDEND PAYMENT
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.196080 Mexican pesos per share on its common stock representing a total amount of $200,001,600.00 M.N. (two hundred million one thousand and six hun
